Suppr超能文献

用于预防接受冠状动脉造影和心导管插入术患者造影剂肾病的静脉输液。

Intravenous fluids for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography and cardiac catheterization.

作者信息

Hong Winston Y, Kabach Mohamad, Feldman George, Jovin Ion S

机构信息

Department of Internal Medicine, Virginia Commonwealth University/Medical College of Virginia, Richmond, VA, USA.

Department of Internal Medicine, McGuire Veterans Administration Medical Center, Richmond, VA, USA.

出版信息

Expert Rev Cardiovasc Ther. 2020 Jan;18(1):33-39. doi: 10.1080/14779072.2020.1724537. Epub 2020 Feb 5.

Abstract

: Contrast-induced nephropathy is a known complication that can occur after intravascular administration of iodinated contrast medium. Its consequences can range from a mild worsening of the renal function to renal failure requiring renal replacement therapy. There is no known effective treatment for contrast-induced nephropathy, and thus, efforts have focused on its prevention. Many approaches have been studied, but the most common strategy in use at the present time is prophylactic intravenous isotonic saline.: This article reviews the data supporting the current practice of prophylactic periprocedural intravenous isotonic saline for lowering the incidence of contrast-induced nephropathy. We reviewed PubMed to search primarily for the latest clinical trials and meta-analyses pertaining to contrast-induced nephropathy and the use of prophylactic measures, specifically intravenous infusion of isotonic saline.: Currently, there are no universally accepted methods for the prevention of contrast-induced nephropathy. The best evidence for contrast-induced nephropathy prophylaxis is the administration of intravenous isotonic saline. Our review article provides an overview of the current knowledge, latest research, and current practice on contrast-induced nephropathy prophylaxis using intravenous isotonic saline administration.

摘要

对比剂肾病是血管内注射碘化造影剂后可能发生的一种已知并发症。其后果从肾功能轻度恶化到需要肾脏替代治疗的肾衰竭不等。目前尚无已知的对比剂肾病有效治疗方法,因此,工作重点一直放在预防上。已经研究了许多方法,但目前最常用的策略是预防性静脉输注等渗盐水。本文综述了支持目前围手术期预防性静脉输注等渗盐水以降低对比剂肾病发生率的现有数据。我们检索了PubMed,主要查找与对比剂肾病及预防措施使用相关的最新临床试验和荟萃分析。目前,尚无普遍接受的预防对比剂肾病的方法。预防对比剂肾病的最佳证据是静脉输注等渗盐水。我们的综述文章概述了目前关于使用静脉输注等渗盐水预防对比剂肾病的知识、最新研究和当前实践。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验